Chinese Academy of Medical Sciences COVID-19 vaccine explained

Chinese Academy of Medical Sciences COVID-19 vaccine, or IMBCAMS COVID-19 vaccine, traded as Covidful (Chinese: s=科维福|p=Kēwéifú), is a COVID-19 vaccine developed by .

Clinical trials

In May 2020, Covidful started phase I/II clinical trial with 942 participants in China.

In January 2021, Covidful started phase III clinical trials with 34,020 from Brazil and Malaysia.

Authorizations

On 9 June 2021, The vaccine has been approved by the Chinese authorities.^[2]

Notes and References

1. Web site: Patent Landscape Report COVID-19-related vaccines and therapeutics.
2. News: Liu R, Woo R . China builds new plant for IMBCAMS COVID-19 vaccine -state media . 15 June 2021 . Reuters . 9 June 2021.